Renin-angiotensin-system blockers and IgG antibodies in end-stage renal disease hemodialysis-receiving patients diagnosed with COVID-19 infection

CONCLUSION: More studies are required to assess whether patients with a SARS-CoV-2 infection that do not have an indication for being prescribed ACEIs/ARBs would benefit from receiving these medications.PMID:37717960 | DOI:10.15537/smj.2023.44.9.20230129

Source: Saudi Medical Journal - September 17, 2023 Category: Middle East Health Authors: Sultan A Almdallaleh Abdulkareem O Alsuwaida Abdulhadi M Altalhi Dina M ALJayar Elzibair E Massad Mazaher M Hamid Parameaswari P Jaganathan Fadel H Al-Hababi Source Type: research